Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling

ZIP9, a novel membrane androgen receptor and zinc transporter protein

(2018) Peter Thomas et al.   GENERAL AND COMPARATIVE ENDOCRINOLOGY

Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling

(2018) Ji-Long Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Structural insights into G-protein-coupled receptor allostery

(2018) David M. Thal et al.   NATURE

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

Membrane androgen receptor characteristics of human ZIP9 (SLC39A) zinc transporter in prostate cancer cells: Androgen-specific activation and involvement of an inhibitory G protein in zinc and MAP kinase signaling

(2017) Peter Thomas et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

Androgen Receptor Signaling in Bladder Cancer

(2017) Peng Li et al.   Cancers

Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies

(2017) Hiroki Ide et al.   PLoS One

On the selectivity of the Gαq inhibitor UBO-QIC: A comparison with the Gαi inhibitor pertussis toxin

(2016) Zhan-Guo Gao et al.   BIOCHEMICAL PHARMACOLOGY

Expression of the zinc importer protein ZIP9/SLC39A9 in glioblastoma cells affects phosphorylation states of p53 and GSK-3β and causes increased cell migration

(2016) Nico Münnich et al.   BIOMETALS

Management of non-muscle invasive bladder cancer: A comprehensive analysis of guidelines from the United States, Europe and Asia

(2016) Wei Shen Tan et al.   CANCER TREATMENT REVIEWS

Osteocalcin and Sex Hormone Binding Globulin Compete on a Specific Binding Site of GPRC6A

(2016) Luca De Toni et al.   ENDOCRINOLOGY

Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes

(2016) Jakub Dobruch et al.   EUROPEAN UROLOGY

Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement

(2016) Matthew I. Milowsky et al.   JOURNAL OF CLINICAL ONCOLOGY

Bladder cancer

(2016) Ashish M Kamat et al.   LANCET

Emerging therapeutic targets in bladder cancer

(2015) Benedito A. Carneiro et al.   CANCER TREATMENT REVIEWS

miR-155 Regulates Glioma Cells Invasion and Chemosensitivity by p38 Isforms In Vitro

(2015) Qiang Liu et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Androgen deprivation therapy prevents bladder cancer recurrence

(2015) Koji Izumi et al.   Oncotarget

Identification and Characterization of Membrane Androgen Receptors in the ZIP9 Zinc Transporter Subfamily: II. Role of Human ZIP9 in Testosterone-Induced Prostate and Breast Cancer Cell Apoptosis

(2014) Peter Thomas et al.   ENDOCRINOLOGY

Identification and Characterization of Membrane Androgen Receptors in the ZIP9 Zinc Transporter Subfamily: I. Discovery in Female Atlantic Croaker and Evidence ZIP9 Mediates Testosterone-Induced Apoptosis of Ovarian Follicle Cells

(2014) A. Håkan Berg et al.   ENDOCRINOLOGY

MEK/ERK pathway is positively involved in hypoxia-induced vasculogenic mimicry formation in hepatocellular carcinoma which is regulated negatively by protein kinase A

(2014) Bin Huang et al.   MEDICAL ONCOLOGY

GPR116, an Adhesion G-Protein-Coupled Receptor, Promotes Breast Cancer Metastasis via the G q-p63RhoGEF-Rho GTPase Pathway

(2013) X. Tang et al.   CANCER RESEARCH

Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver

(2013) C Chang et al.   ONCOGENE

Nuclear Hormone Receptor Signals as New Therapeutic Targets for Urothelial Carcinoma

(2012) H. Miyamoto et al.   CURRENT CANCER DRUG TARGETS

Cancer statistics, 2011

(2011) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

GPRC6A regulates prostate cancer progression

(2011) Min Pi et al.   PROSTATE

GPRC6A Mediates the Non-genomic Effects of Steroids

(2010) Min Pi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sex-specific hormone receptors in urothelial carcinomas of the human urinary bladder: A comparative analysis of clinicopathological features and survival outcomes according to receptor expression

(2009) Can Tuygun et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Androgen receptor is a tumor suppressor and proliferator in prostate cancer

(2008) Y. Niu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Non-genomic actions of androgens

(2007) C.D. Foradori et al.   FRONTIERS IN NEUROENDOCRINOLOGY